mr. harper? >> yes. i have one very big difference with this, and i've talked to mark about this already. the first level, the first round of tenant improvements should not even be an operating expense. that is part of finishing the building and doing the building, and we should make that distinction because that's the way it's made in the private sector. when you get four or five people together as an llp doing a commercial building, they're expected to give all of the money necessary to get the building up and running, and that includes tenant improvement allowance. successive tenant improvements are then considered operating expenses. it's considered if you've been operating, you have built up a reserve and you've done all those things so when tenants change, then, operations take over. that's the way it works most of the time, and that's, you know, what investors want to see is an end to their duties, their contractual duties to contribute money until the building is finished. so i think this is just

mr. jarvin first for your testimony. >> good morning, chairman harper. ranking member degette and other members of the subcommittee. i am gloria jarman, deputy inspector general for auditor service, u.s. department of health and human services. i appreciate the opportunity to appear before you today conduct an audits, evaluations and inspections aimed at food safety is a priority for oig and remains key to our mission of protecting the health and safety of the american people. i am here today to discuss our recently published audit report on the food recall process of the food and drug administration and our recommendations for imflaui improving that process. this document reviewed doomts take for 30 recalls which where are select from the 1557 food recalls reported to fda between october, 2012, and may 4th, 2015. for the 30 recalls we reviewed, we found that fda's food recall process was not always effective and efficient in ensuring the safety of the nation's food supply. specifically, we identified deficiencies in fda's oversight of recall initiation,

mr. baldwin. >> good morning, chairman portman, chairman johnson, ranking member harper and distinguished members. thank you for the opportunity to discuss the opioid crisis in the united states and the efforts of u.s. immigration and customs enforcement, homeland security to disrupt and dismantle the criminal elements responsible for manufacturing and distribution of dangerous opioids. as the largest investigation agency within the department of homeland security, i.c.e. investigates and enforces more than 400 criminal statutes. they use this authority to investigate cross-border activity and work in close collaboration with u.s. customs and drug protections and the united states and postal inspection services in a unified effort with both domestic and international partners to target trans national criminal organizations supplying dangerous opioids to the u.s. i would like to highlight fen tan n tanyl coming into the united states. we have identified china as a primary source. their precursors are most often produced in china shipped by mail carriers directly to the united states or to

mr. stern for five minutes for the purpose of the has written testimony. >> morning, chairman harper, rankingmember to get members of the subcommittee. and douglas stearn, office of the import operations and office of regulatory affairs and the acting deputy director for regulatory affairs for food safety. we appreciate the opportunity to provide you -- i'm sorry. is that better? we appreciate the opportunity to provide you with information how we oversee recalls of regulated products could fda committed to continuously improving practices to ensure food recalls are initiated, overseen and completed promptly and effectively to best protect consumers. in this regard we appreciate the office of inspector general focus on the subject and would like to thank the committee for the opportunity to report on major changes fda has made in response to oig investigation. when we learn about foot in the marketplace that may be unsafe, and must act quickly to keep people from getting sick or being harmed. fda has authority to act in a variety of ways but often the fastest and most efficient way to ensure

harper. and director kim is expected. and director reiskin. and director sartipi. and chair nuru. >> present. >> clerk: mr. chairman, you have a quorum. go ahead and call your next item. item 3 is communications and i understand that the chair has something -- >> chair mohammed nuru: so i think that everyone is mourning the passing of the mayor in the last few days and i know that for me it's been difficult because he was not only a boss but a close friend of mine, but more importantly he was a champion of this project. when i joined the board there were a lot of financial needs and concerns and trying to make sure that we got the project to the way that it is now and we were able to finish it and through his leadership, really stepped up and did everything on behalf of the city. to make sure that the city could do its part. of recent, i mean, we've had closed discussions about the asidelinement and what should -- alignment and what would happen with phase two and i think that we should take a moment of silence to mourn him. thank you. >> clerk: we'll move into the next item on the agenda. board of directors new business. seeing none,

harper say it's time to eat carbs again? all the answers right now on "page six tv." [ applause ] >> welcome to "page six tv." i'm john fugelsang. here with page six senior reporter mrrlos greer, variety writer miss elizabeth wagmeister, and host of sirius xm's bevelation, the iconic bevy smith. here are today's top stories. now, first, you can read page six, and you can watch it, and now, shucks, you can wear it, too. >> woo! >> we are very honored to reveal that page six

mr. stern for five minutes for the purposes of the summary of his written testimony. thank you, and welcome. >> thank you, sir. good morning, chairman harper and ranking member daggett and members of the subcommittee. i am douglas stern, director was office of enforcement and import operations and the acting deputy director for regulatory affairs at the center for food safety and applied nutrition. we appreciate the opportunity to provide you with information -- oh, i'm sorry. is that better? >> we appreciate the opportunity to provide you with information about how we oversee recalls of products. fda continues to improve practices to neck sure recalls are initiated and overseen and completed promptly and effectively to best protect consumers. in this regard, we appreciate the office offen spector general's focus on the subject. i would like to thank the committee for the opportunity to report on major changes fda has made in response to oig's investigation. when we learn about a food in the marketplace, we must keep people from getting sick and being harmed. fda has the ability to act in a variety of ways and the fastest and most efficien

mr. parnell is currently serving a 28 year sentence in prison for his actions. and while this case of pca is the exception and not the rule, fortunately, food born illnesses remain a major concern. chairman harper ran through the numbers. each year 48,000 are sick end, 3,000 die, it has been on the government accountability high risk list since 2007. and just in the past few months dozens of people in the united states and canada and two died from e. coli leafy green. i was glad to see the fda commissioner commitment with yesterday's announcement that the fda will accelerate the release of information before they officially classified as recall items. we look forward to hearing from the fda today what it plans to do to address the recommendations from the oig. we also look forward to the fda implementing the other expert recommendations to provide proper funding and permanent staff to the fda office that oversees the labs which do play a critical role. i thank you all for testifying today and recent work in december as well as early alert they issued in june of 2016. recent work builds on the past work most notably two reports related to food recalls related in 2009 and 11. while the reports we